94 related articles for article (PubMed ID: 26861551)
1. Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma.
Biggadike K; Ahmed M; Ball DI; Coe DM; Dalmas Wilk DA; Edwards CD; Gibbon BH; Hardy CJ; Hermitage SA; Hessey JO; Hillegas AE; Hughes SC; Lazarides L; Lewell XQ; Lucas A; Mallett DN; Price MA; Priest FM; Quint DJ; Shah P; Sitaram A; Smith SA; Stocker R; Trivedi NA; Tsitoura DC; Weller V
J Med Chem; 2016 Mar; 59(5):1711-26. PubMed ID: 26861551
[TBL] [Abstract][Full Text] [Related]
2. Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: Use of translational biomarkers to guide dosing and confirm target engagement.
Tsitoura D; Ambery C; Price M; Powley W; Garthside S; Biggadike K; Quint D
Clin Pharmacol Ther; 2015 Oct; 98(4):369-80. PubMed ID: 26044169
[TBL] [Abstract][Full Text] [Related]
3. Intranasal GSK2245035, a Toll-like receptor 7 agonist, does not attenuate the allergen-induced asthmatic response in a randomized, double-blind, placebo-controlled experimental medicine study.
Siddall H; Quint D; Pandya H; Powley W; Shabbir S; Hohlfeld JM; Singh D; Lee L
PLoS One; 2020; 15(11):e0240964. PubMed ID: 33166307
[TBL] [Abstract][Full Text] [Related]
4. Safety and pharmacodynamics of intranasal GSK2245035, a TLR7 agonist for allergic rhinitis: A randomized trial.
Ellis AK; Tsitoura DC; Quint D; Powley W; Lee LA
Clin Exp Allergy; 2017 Sep; 47(9):1193-1203. PubMed ID: 28681506
[TBL] [Abstract][Full Text] [Related]
5. GSK2245035, a TLR7 agonist, Does Not Increase Pregnancy Loss in Cynomolgus Monkeys.
Posobiec LM; Hillegas AE; Baker A; Phadnis-Moghe AS; Maier CC; Stanislaus DJ; Bray M; Price MA
J Reprod Immunol; 2021 Feb; 143():103242. PubMed ID: 33212303
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of 8-oxoadenine derivatives as potent Toll-like receptor 7 agonists with high water solubility.
Nakamura T; Wada H; Kurebayashi H; McInally T; Bonnert R; Isobe Y
Bioorg Med Chem Lett; 2013 Feb; 23(3):669-72. PubMed ID: 23265901
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma.
Xirakia C; Koltsida O; Stavropoulos A; Thanassopoulou A; Aidinis V; Sideras P; Andreakos E
Am J Respir Crit Care Med; 2010 Jun; 181(11):1207-16. PubMed ID: 20224068
[TBL] [Abstract][Full Text] [Related]
8. Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activity.
Bazin HG; Bess LS; Livesay MT; Li Y; Cybulski V; Miller SM; Johnson DA; Evans JT
Bioorg Med Chem Lett; 2020 Mar; 30(6):126984. PubMed ID: 32001135
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug concept.
Kurimoto A; Hashimoto K; Nakamura T; Norimura K; Ogita H; Takaku H; Bonnert R; McInally T; Wada H; Isobe Y
J Med Chem; 2010 Apr; 53(7):2964-72. PubMed ID: 20232824
[TBL] [Abstract][Full Text] [Related]
10. Structural requirements for TLR7-selective signaling by 9-(4-piperidinylalkyl)-8-oxoadenine derivatives.
Bazin HG; Li Y; Khalaf JK; Mwakwari S; Livesay MT; Evans JT; Johnson DA
Bioorg Med Chem Lett; 2015 Mar; 25(6):1318-23. PubMed ID: 25698055
[TBL] [Abstract][Full Text] [Related]
11. The TLR7 ligand 9-benzyl-2-butoxy-8-hydroxy adenine inhibits IL-17 response by eliciting IL-10 and IL-10-inducing cytokines.
Vultaggio A; Nencini F; Pratesi S; Maggi L; Guarna A; Annunziato F; Romagnani S; Parronchi P; Maggi E
J Immunol; 2011 Apr; 186(8):4707-15. PubMed ID: 21389257
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and immunostimulatory activity of 8-substituted amino 9-benzyladenines as potent Toll-like receptor 7 agonists.
Jin G; Wu CC; Tawatao RI; Chan M; Carson DA; Cottam HB
Bioorg Med Chem Lett; 2006 Sep; 16(17):4559-63. PubMed ID: 16784848
[TBL] [Abstract][Full Text] [Related]
13. Treatment with 8-OH-modified adenine (TLR7 ligand)-allergen conjugates decreases T helper type 2-oriented murine airway inflammation.
Nencini F; Pratesi S; Petroni G; Filì L; Cardilicchia E; Casini A; Occhiato EG; Calosi L; Bani D; Romagnani S; Maggi E; Parronchi P; Vultaggio A
Immunology; 2015 Aug; 145(4):570-82. PubMed ID: 25930741
[TBL] [Abstract][Full Text] [Related]
14. Peptides conjugated to 2-alkoxy-8-oxo-adenine as potential synthetic vaccines triggering TLR7.
Gential GPP; Hogervorst TP; Tondini E; van de Graaff MJ; Overkleeft HS; Codée JDC; van der Marel GA; Ossendorp F; Filippov DV
Bioorg Med Chem Lett; 2019 Jun; 29(11):1340-1344. PubMed ID: 30952595
[TBL] [Abstract][Full Text] [Related]
15. Discovery of N-sulfonyl-7-azaindoline derivatives as potent, orally available and selective M(4) muscarinic acetylcholine receptor agonists.
Suwa A; Konishi Y; Uruno Y; Takai K; Nakako T; Sakai M; Enomoto T; Ochi Y; Matsuda H; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
Bioorg Med Chem Lett; 2014 Jul; 24(13):2909-12. PubMed ID: 24852118
[TBL] [Abstract][Full Text] [Related]
16. Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy.
Dovedi SJ; Adlard AL; Ota Y; Murata M; Sugaru E; Koga-Yamakawa E; Eguchi K; Hirose Y; Yamamoto S; Umehara H; Honeychurch J; Cheadle EJ; Hughes G; Jewsbury PJ; Wilkinson RW; Stratford IJ; Illidge TM
Oncotarget; 2016 Mar; 7(13):17035-46. PubMed ID: 26959743
[TBL] [Abstract][Full Text] [Related]
17. Temporal cytokine and lymphoid responses to an inhaled TLR7 antedrug agonist in the cynomolgus monkey demonstrates potential safety and tolerability of this approach.
Bell J; Dymond M; Biffen M; Delaney S; Keeling D; Zhang H; Robinson I
Toxicol Appl Pharmacol; 2018 Jan; 338():9-19. PubMed ID: 29122671
[TBL] [Abstract][Full Text] [Related]
18. Discovery of N-substituted 7-azaindoline derivatives as potent, orally available M1 and M4 muscarinic acetylcholine receptors selective agonists.
Takai K; Inoue Y; Konishi Y; Suwa A; Uruno Y; Matsuda H; Nakako T; Sakai M; Nishikawa H; Hashimoto G; Enomoto T; Kitamura A; Uematsu Y; Kiyoshi A; Sumiyoshi T
Bioorg Med Chem Lett; 2014 Jul; 24(14):3189-93. PubMed ID: 24856064
[TBL] [Abstract][Full Text] [Related]
19. TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways.
Duechs MJ; Hahn C; Benediktus E; Werner-Klein M; Braun A; Hoymann HG; Gantner F; Erb KJ
Pulm Pharmacol Ther; 2011 Apr; 24(2):203-14. PubMed ID: 21195789
[TBL] [Abstract][Full Text] [Related]
20. 2-Azidoalkoxy-7-hydro-8-oxoadenine derivatives as TLR7 agonists inducing dendritic cell maturation.
Weterings JJ; Khan S; van der Heden van Noort GJ; Melief CJ; Overkleeft HS; van der Burg SH; Ossendorp F; van der Marel GA; Filippov DV
Bioorg Med Chem Lett; 2009 Apr; 19(8):2249-51. PubMed ID: 19299126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
